FDA Approves Cholesterol Lowering Drug
Dec-28-2012

Aegerion Pharmaceuticals announced that the U.S. Food and Drug Administration has approved use of Juxtapid (lomitapide) pills as an accompaniment to a low-fat diet and other lipid-lowering treatments.

Juxtapid is for patients with homozygous familial hypercholesterolemia (HoFH), a critical, uncommon genetic disease that inhibits the function of the receptor that eliminates bad cholesterol from the body. This loss of function of the LDL receptor function causes high levels of cholesterol in the blood.

HoFH is characterized by untimely atherosclerosis, a blocking of the arteries and can result in heart attacks at an early age.

Read the rest of the article by clicking the link below.

Visit Website

Posted by Ken at 12:00 AM - Link to this entry  |  Share this entry  |  Print